MSK Investigators Report Sialic Acid Test 95% Accurate; Negative Immunotherapy Results Told
In Brief: House, Senate Authorization Measuring Waiting Floor Action; Money Bill Markups Pending
Breast Cancer A Heterogeneous Disease, Concepts Changing: Fisher
Manipulating The Therapeutic Index Clinical Trials Goal: Hellman
NCA Uneasy Over Possible NIH Takeover Of FCRC, But It Won’t Happen
HHS Carcinogen Guidelines Draft
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget
- NIH calls for comment on proposal to limit the number of RPGs per PI
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe









